Home > Insider Trading > Filing (0001104659-21-019903)

Filing Details

Accession Number:: 0001104659-21-019903
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-02-10 17:00:40
Reporting Period:: 2021-02-08

Accepted Time:: 2021-02-10 17:00:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1554859	Semler Scientific Inc.	SMLR	Electromedical & Electrotherapeutic Apparatus (3845)	261367393

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1594342	Douglas Murphy-Chutorian	C/O Semler Scientific, Inc. 2340-2348 Walsh Avenue, Suite 2344 Santa Clara CA 95051	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-02-08	1,250	$0.52	1,250	No	4	M	Direct
Common Stock	Disposition	2021-02-08	50	$98.00	1,200	No	4	S	Direct
Common Stock	Disposition	2021-02-08	300	$99.37	900	No	4	S	Direct
Common Stock	Disposition	2021-02-08	250	$100.08	650	No	4	S	Direct
Common Stock	Disposition	2021-02-08	295	$101.35	355	No	4	S	Direct
Common Stock	Disposition	2021-02-08	55	$102.92	300	No	4	S	Direct
Common Stock	Disposition	2021-02-08	300	$103.05	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Option (Right to Buy)	Disposition	2021-02-08	1,250	$0.00	1,250	$0.52

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
16,250		2022-11-21	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	53,571	Indirect	By Trust

Footnotes

Shares sold pursuant to a 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.00 to $99.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.00 to $101.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.10 to $103.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 5 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.01 to $103.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 6 to this Form 4.
Shares are held by the Murphy-Chutorian Family Trust U/D/T dated January 13, 1997, of which the Reporting Person is co-Trustee with his spouse.
Fully vested and exercisable.